hantavirus
negativesens
rna
virus
transmit
human
small
anim
host
differ
viral
speci
associ
one
two
diseas
syndrom
hemorrhag
fever
renal
syndrom
hfr
hantaviru
pulmonari
syndrom
hp
hantaan
viru
htnv
primarili
found
asia
among
preval
hfrscaus
hantavirus
case
fatal
rate
puumala
viru
puuv
caus
hfr
case
europ
though
case
fatal
rate
lower
current
fda
licens
vaccin
therapeut
either
hfr
hp
syrian
hamster
mesocricetu
auratu
typic
anim
use
model
hantaviru
infect
diseas
and
viru
andv
hpscaus
hantaviru
caus
lethal
diseas
immunocompet
hamster
numer
hpscaus
hantavirus
includ
sin
nombr
viru
snv
choclo
viru
caus
lethal
diseas
hamster
immunosuppress
dexamethason
cyclophosphamid
contrast
hpscaus
hantavirus
exposur
hamster
hfrscaus
hantavirus
htnv
puuv
dobrava
dobv
seoul
seov
lead
asymptomat
infect
despit
viral
dissemin
even
immunosuppress
hooper
lab
unpublish
data
studi
hamster
expos
high
dose
htnv
puuv
far
exceed
infecti
dose
viru
develop
character
uniformli
infect
lowdos
challeng
model
enhanc
hamster
model
use
vaccin
therapeut
test
report
present
lowdos
hamster
infect
model
htnv
puuv
infect
anim
ferret
mustela
putoriu
furo
becom
popular
anim
model
number
respiratori
pathogen
includ
influenza
coronaviru
nipah
viru
morbilliviru
due
similar
lung
physiolog
human
addit
recent
describ
diseas
model
two
hemorrhag
fever
virus
bundibugyo
viru
ebola
viru
support
viral
replic
without
prior
adapt
hantavirusrel
human
diseas
occur
aerosol
transmiss
viru
excreta
secreta
infect
rodent
model
viral
infect
ferret
well
suit
studi
demonstr
ferret
capabl
infect
high
titer
htnv
puuv
though
asid
gradual
weight
loss
infect
anim
exhibit
clinic
symptom
impair
renal
function
establish
infect
rhesu
macaqu
macaca
mulatta
hfrscaus
hantavirus
dobv
seov
htnv
puuv
lead
asymptomat
infect
seroconvers
infect
cynomolgu
macaqu
macaca
fasciculari
puuv
lead
mild
diseas
character
lethargi
mild
proteinuria
hematuria
kidney
patholog
similar
mild
hfr
human
howev
macaqu
larg
size
cost
limit
use
therapeut
studi
especi
test
articl
avail
limit
often
case
passiv
transfer
studi
common
marmoset
callithrix
jacchu
becom
popular
infecti
diseas
studi
genet
similar
human
cost
rel
safeti
small
size
make
attract
altern
tradit
nonhuman
primat
speci
marmoset
use
diseas
model
viral
agent
includ
dengu
viru
hepat
c
viru
influenza
viru
lassa
fever
viru
orthopox
virus
rift
valley
fever
viru
eastern
equin
enceph
viru
filovirus
studi
demonstr
exposur
marmoset
htnv
lead
asymptomat
infect
character
high
level
neutral
antibodi
first
report
hantaviru
infect
marmoset
medic
countermeasur
product
includ
biolog
eg
vaccin
antibodi
small
molecul
drug
use
prevent
combat
infecti
diseas
outbreak
studi
present
three
anim
model
htnv
infect
two
model
puuv
infect
use
evalu
efficaci
medic
countermeasur
intend
prevent
mitig
infect
eg
vaccin
virus
induct
steril
immun
htnv
strain
puuv
strain
puuv
strain
beaumont
seloign
gift
piet
mae
leuven
beligium
propag
vero
cell
vero
atcc
crl
flask
cemem
media
minim
essenti
medium
salt
emem
contain
heat
inactiv
fetal
bovin
serum
glutamin
nonessenti
amino
acid
mm
hepe
ph
antibiot
penicillin
uml
amphotericin
b
gentamicin
mgml
viru
collect
infectedmonolay
supernat
cell
debri
remov
low
speed
centrifug
rpm
tabl
top
centrifug
htnv
puuv
strain
twice
plaqu
purifi
accord
publish
method
viru
stock
aliquot
store
colder
viru
ident
confirm
sequenc
stock
anim
research
conduct
iacuc
approv
protocol
usamriid
usda
registr
number
olaw
assur
number
complianc
anim
welfar
act
feder
statut
regul
relat
anim
experi
involv
anim
facil
research
conduct
fulli
accredit
associ
assess
accredit
laboratori
anim
care
intern
adher
principl
state
guid
care
use
laboratori
anim
nation
research
council
femal
syrian
hamster
wk
age
envigo
indianapoli
anesthet
inhal
vapor
isofluran
use
impac
veterinari
anesthesia
machin
anesthet
anim
inject
indic
concentr
viru
dilut
pb
intramuscular
im
inject
caudal
thigh
consist
ml
deliv
syring
needl
intranas
instil
consist
total
volum
deliv
per
nare
plastic
pipett
tip
blood
sampl
vena
cava
occur
previous
state
method
anesthesia
limit
hamster
total
blood
volum
per
week
time
arriv
anim
random
experiment
group
anim
hous
small
anim
pan
exceed
four
anim
pan
climat
humid
control
anim
biosafeti
level
lightdark
cycl
anim
pellet
food
water
provid
ad
libitum
enrich
form
toy
nest
materi
supplement
treat
provid
human
endpoint
condit
establish
decreas
mobil
inabl
obtain
food
water
subdu
respons
stimul
anim
monitor
daili
experi
infect
anim
becom
ill
criteria
met
anim
euthan
termin
blood
collect
heart
administr
kax
usamriid
fort
detrick
md
prior
intracardiac
inject
pentobarbit
sodium
usamriid
end
studi
due
lack
ill
pain
relief
asid
anesthesia
procedur
requir
group
hamster
use
determin
infecti
dose
numer
simul
use
sa
probit
indic
minimum
group
span
infect
rate
anim
per
group
yield
stabl
estim
valu
confid
interv
reach
approxim
monotom
assumpt
respons
profil
intermedi
dose
initi
select
dosag
meet
desir
infect
rate
span
dosag
group
repeat
lead
hamster
per
group
serial
euthanasia
studi
three
hamster
per
group
use
minimum
number
requir
provid
collect
suffici
sampl
detect
antibodi
viral
kinet
tissu
experi
presera
anim
serv
neg
control
adult
femal
neuter
descent
ferret
marshal
farm
north
rose
ny
anesthet
inhal
vapor
isofluran
use
impac
veterinari
anesthesia
machin
im
inject
telazol
zoeti
parsippani
nj
inject
im
blood
sampl
conduct
condit
hamster
intraperiton
ip
inject
consist
ml
deliv
ml
syring
needl
microchip
bmd
seaford
de
use
identifi
ascertain
temperatur
ferret
experi
first
ferret
challeng
studi
faulti
chip
lead
inaccur
temperatur
read
use
identif
purpos
anim
random
upon
receipt
experiment
group
ferret
social
hous
metal
cage
two
cage
sight
line
addit
anim
studi
climat
humid
control
light
dark
cycl
cage
nest
box
bed
materi
numer
tube
shelf
play
ferret
access
pellet
food
supplement
treat
potabl
water
autom
water
system
enrich
form
manipulada
tube
ball
mirror
food
provid
anim
observ
daili
train
personnel
addit
gener
husbandri
assess
human
euthanasia
criteria
defin
dyspnea
loss
mobil
obtain
food
water
weight
loss
end
experi
termin
blood
sampl
collect
heart
administr
kax
prior
intracardiac
inject
pentobarbit
sodium
pain
relief
asid
anesthesia
procedur
use
diseas
occur
independ
four
ferret
probabl
experi
odd
favor
produc
least
one
diseas
ferret
convers
failur
observ
diseas
ferret
group
four
yield
confid
interv
extend
confid
admit
true
diseas
rate
may
less
reason
group
four
ferret
use
experi
experi
presera
anim
serv
neg
control
adult
marmoset
weigh
anesthet
inhal
vapor
isofluran
use
impac
veterinari
anesthesia
machin
anesthet
anim
inject
indic
concentr
viru
dilut
pb
im
inject
caudal
thigh
consist
ml
deliv
syring
needl
blood
sampl
femor
vein
occur
previous
state
method
anesthesia
limit
marmoset
total
blood
volum
per
week
time
euthanasia
termin
blood
sampl
collect
heart
anesthet
im
inject
telazol
prior
intracardiac
administr
pentobarbit
sodium
anim
hous
contain
previous
describ
brief
anim
singli
hous
metal
cage
meet
current
standard
climat
humid
control
room
anim
fed
pellet
food
supplement
fruit
treat
daili
provid
potabl
water
automat
water
system
ad
libitum
enrich
form
manipulada
ie
toy
metal
mirror
forag
devic
treat
fruit
provid
daili
anim
observ
daili
train
personnel
addit
gener
husbandri
assess
anim
observ
daili
train
personnel
addit
gener
husbandri
assess
anim
found
moribund
defin
labor
breath
decreas
food
consumpt
persist
prostrat
moder
unrespons
would
euthan
human
endpoint
criteria
howev
anim
becom
ill
studi
criteria
met
addit
pain
relief
asid
anesthesia
procedur
necessari
work
perform
laboratori
marmoset
studi
requir
sampl
size
adequ
power
determin
incid
seroconvers
significantli
greater
would
expect
popul
sampl
size
allow
experiment
detect
seroconvers
least
anim
versu
expect
popul
constant
confid
level
use
onetail
binomi
test
proport
enzymelink
immunosorb
assay
elisa
use
detect
nucleocapsid
protein
n
specif
antibodi
nelisa
describ
previous
speciesspecif
secondari
antibodi
use
follow
concentr
peroxidelabel
antihamst
sera
care
gaithersburg
md
peroxidelabel
antiferret
sigma
aldrich
st
loui
mo
alkalin
phosphatas
conjug
antimonkey
milliporesigma
st
loui
mo
assay
use
peroxid
label
antibodi
develop
tmb
microwel
peroxidas
substrat
sera
care
absorb
nm
assay
use
alkalin
phosphatas
conjug
antibodi
develop
pnitrophenyl
phosphat
pnpp
thermofish
scientif
waltham
nm
sampl
consid
posit
peak
optic
densiti
od
valu
greater
either
background
valu
averag
three
neg
control
time
standard
deviat
whichev
higher
specif
od
sum
summat
valu
greater
background
repres
area
titer
curv
prnt
assay
perform
previous
describ
minor
modif
htnvinfect
monolay
fix
day
postinfect
puuvinfect
monolay
fix
day
post
infect
ml
formalin
per
well
immunostain
perform
previous
describ
sera
sampl
assay
duplic
begin
final
dilut
valu
repres
reciproc
dilut
serum
neutral
viru
approxim
mg
organ
tissu
homogen
ml
trizol
thermofish
waltham
reagent
use
tube
gentlemac
miltenyi
biotec
auburn
ca
dissoci
system
rna
set
rna
extract
trizol
per
manufactur
protocol
nanodrop
use
determin
rna
concentr
rais
either
ultrapur
distil
water
thermofish
realtim
pcr
conduct
biorad
cfx
thermal
cycler
use
either
invitrogen
power
sybr
green
rnatoct
onestep
kit
thermofish
brilliant
ii
qrtpcr
step
master
mix
agil
santa
clara
ca
accord
manufactur
protocol
spike
assay
master
mix
spike
either
htnv
puuv
viral
rna
prior
addit
sampl
htnv
primer
sequenc
cat
gaa
ggc
aga
aga
gat
tcc
ctg
ttt
gtt
gca
cycl
condit
min
min
follow
cycl
sec
sec
data
acquisit
occur
follow
anneal
step
puuv
primer
sequenc
caa
caa
aca
gtg
tca
ttc
aca
tca
agg
aca
ttt
cca
famconjug
probe
acc
cga
ctg
gga
ttg
aac
ctg
cycl
condit
min
min
follow
cycl
sec
min
flask
one
week
old
vero
cell
infect
urin
plu
addit
cemem
media
hr
adsorpt
volum
rais
ml
day
post
infect
supernat
collect
frozen
use
infect
fresh
vero
cell
later
time
point
hr
adsorpt
volum
rais
ml
day
ml
cultur
supernat
collect
frozen
volum
cemem
flask
rais
ml
fresh
media
approxim
organ
tissu
homogen
ml
cemem
media
use
tube
gentlemac
dissoci
system
rna
set
plaqu
assay
use
urin
sera
organ
homogen
perform
begin
dilut
describ
minor
modif
spike
plaqu
assay
protocol
ident
except
equival
amount
viru
spike
either
media
alon
control
dilut
organ
homogen
htnvinfect
monolay
fix
day
postinfect
puuvinfect
monolay
fix
day
post
infect
ml
formalin
per
well
immunostain
perform
previous
describ
follow
euthanasia
necropsi
perform
sampl
collect
asept
virolog
studi
describ
hamster
ferret
sampl
follow
collect
heart
lung
liver
spleen
kidney
brain
urin
addit
ferret
sampl
intestin
adren
gland
pituitari
gland
eye
collect
sampl
follow
collect
marmoset
heart
lung
liver
spleen
kidney
intestin
brain
virolog
sampl
collect
major
intern
organ
anim
also
sampl
histolog
tissu
fix
neutralbuff
formalin
day
tissu
trim
process
vacuum
increas
concentr
alcohol
embed
paraffin
paraffin
embed
tissu
section
cut
mount
glass
slide
stain
hematoxylin
eosin
h
e
mount
glass
coverslip
routin
histolog
evalu
paraffinembed
tissu
use
produc
h
estain
histolog
slide
also
util
immunohistochemistri
ihc
studi
hamster
immunoloc
htnv
tissu
perform
immunoperoxidas
procedur
horseradish
peroxidas
envis
system
dako
accord
manufactur
direct
primari
antibodi
antihtnv
nucleocapsid
rabbit
polyclon
antibodi
dilut
ferret
hamster
bei
resourc
manassa
va
deparaffin
peroxidas
block
tissu
section
pretreat
proteinas
k
min
room
temperatur
rins
cover
primari
antibodi
incub
room
temperatur
min
rins
peroxidaselabel
polym
secondari
antibodi
appli
min
slide
rins
substratechromogen
solut
diaminobenzidin
dako
santa
clara
ca
appli
min
substratechromogen
solut
rins
slide
slide
stain
hematoxylin
rins
section
dehydr
clear
xyless
coverslip
place
indic
day
anesthet
ferret
inject
ip
water
solubl
cyp
baxter
health
care
corpor
deerfield
il
indic
dosag
per
bodi
weight
drug
dilut
steril
phosphatebuff
salin
pb
ph
first
experi
ferret
administ
load
dose
mgkg
day
post
infect
mainten
dose
mgkg
administ
everi
day
euthanasia
second
experi
ferret
administ
load
dose
mgkg
day
mainten
dose
mgkg
day
administr
cyp
discontinu
day
due
secondari
infect
combat
infect
rapid
onset
fever
weight
loss
ferret
treat
im
enrofloxicin
norbrook
laboratori
overland
park
ks
twice
daili
per
veterinarian
instruct
start
day
begin
day
resumpt
immunosuppress
ferret
treat
prophylact
mgkg
im
enrofloxicin
daili
blood
sampl
ml
collect
lithium
heparin
capillari
blood
collect
tube
analyz
use
advia
hematolog
analyz
softwar
version
per
manufactur
recommend
dog
set
use
complet
blood
count
cbc
guinea
pig
set
use
white
blood
cell
differenti
wbc
hamster
ferret
dog
set
use
cbc
wbc
psvna
use
detect
neutral
antibodi
sera
describ
previous
replicationrestrict
recombin
vesicular
stomat
viru
rvsv
express
luciferas
pseudotyp
hantaan
glycoprotein
first
heatinactiv
sera
dilut
follow
fivefold
serial
dilut
mix
equal
volum
minimum
essenti
medium
salt
fetal
bovin
sera
contain
fluoresc
focu
unit
hantaan
pseudovirion
mixtur
incub
overnight
follow
incub
inocul
onto
vero
cell
monolay
clear
bottom
blackwal
plate
duplic
plate
incub
hr
media
discard
cell
lyse
accord
luciferas
kit
protocol
promega
madison
wi
tecan
pro
use
acquir
luciferas
data
valu
graph
use
graphpad
prism
version
use
calcul
percent
neutral
normal
cell
alon
pseudovirion
alon
minimum
maximum
signal
respect
percent
neutral
valu
duplic
serial
dilut
plot
fifti
percent
psvna
titer
interpol
curv
geometr
mean
titer
calcul
blood
collect
serum
separ
tube
spun
g
isol
sera
ferret
sera
analyz
piccolo
comprehens
metabol
panel
marmoset
sera
analyz
piccolo
gener
chemistri
panel
per
manufactur
instruct
abaxi
global
diagnost
union
citi
ca
urin
express
anesthet
ferret
analyz
urinalysi
regent
strip
vwr
radnor
pa
bayesian
probit
model
use
estim
highest
posterior
densiti
interv
infecti
dose
calcul
student
ttest
mannwhitney
test
use
compar
white
blood
cell
level
pre
postcyp
administr
pvalu
consid
signific
standard
deviat
data
assess
ensur
data
normal
distribut
prior
use
student
ttest
analys
conduct
use
graphpad
prism
version
bayesian
analys
perform
use
sa
previous
demonstr
syrian
hamster
capabl
infect
hfrscaus
hantavirus
develop
sign
clinic
diseas
develop
standard
model
htnv
puuv
infect
futur
evalu
vaccin
medic
countermeasur
group
hamster
expos
serial
tenfold
dilut
either
htnv
puuv
either
im
rout
pfu
htnv
pfu
puuv
day
post
infect
hamster
termin
bled
infect
statu
monitor
nelisa
titer
fig
data
dose
requir
infect
calcul
tabl
character
lowdos
standard
hamster
infect
model
hfrscaus
hantavirus
hamster
serial
sacrific
studi
perform
hamster
challeng
either
pfu
htnv
im
pfu
htnv
pfu
puuv
im
pfu
puuv
variou
day
post
infect
group
three
hamster
euthan
monitor
viral
serolog
paramet
seroconvers
occur
least
partial
day
post
htnv
infect
day
post
puuv
infect
seroconvers
day
post
htnv
im
infect
incomplet
though
viral
genom
recov
hamster
euthan
day
indic
product
htnv
infect
occur
fig
confirm
seroconvers
hamster
euthan
day
assay
neutral
antibodi
prnt
regardless
nelisa
seroconvers
statu
htnv
infect
hamster
nelisa
titer
neutral
antibodi
measur
one
full
neutral
viru
dilut
sera
fig
similarli
puuv
hamster
nelisa
titer
neutral
antibodi
measur
though
three
five
puuv
challeng
hamster
complet
neutral
viru
dilut
sera
fig
two
three
puuv
im
challeng
hamster
seroconvert
day
post
infect
low
level
neutral
antibodi
none
puuv
challeng
hamster
seroneg
nelisa
neutral
antibodi
htnv
puuv
infect
hamster
infect
via
im
rout
lead
robust
neutral
antibodi
respons
inrout
kinet
htnv
puuv
infect
heart
lung
liver
spleen
kidney
brain
monitor
rtpcr
plaqu
assay
fig
htnv
infect
either
im
rout
result
persist
infect
high
level
viral
genom
detect
heart
lung
kidney
brain
htnv
infect
hamster
begin
either
day
post
infect
fig
infect
kidney
brain
found
examin
hamster
begin
either
day
post
infect
high
titer
viral
genom
detect
heart
lung
present
one
two
hamster
time
point
low
level
viral
genom
detect
day
post
infect
liver
htnv
im
infect
hamster
fig
hardli
viral
genom
detect
spleen
fig
confirm
lack
viral
genom
spleen
due
presenc
inhibitor
spleen
sampl
im
infect
hamster
spike
htnv
prior
rtpcr
signific
inhibit
spike
rna
note
indic
htnv
infect
result
viru
dissemin
spleen
fig
detect
puuv
organ
transient
im
infect
occur
day
heart
liver
kidney
brain
viru
detect
spleen
fig
viral
genom
persist
lung
detect
least
one
three
hamster
onaft
day
post
infect
fig
small
amount
viral
genom
detect
brain
puuv
infect
hamster
day
post
challeng
viral
genom
detect
organ
time
point
post
puuv
infect
fig
serum
viremia
detect
hamster
challeng
htnv
im
day
post
infect
though
presenc
viru
sporad
except
day
serum
viremia
detect
two
hamster
challeng
htnv
one
day
one
day
serum
viremia
detect
hamster
challeng
puuv
either
rout
fig
similarli
presenc
viral
genom
sporad
detect
urin
htnv
infect
hamster
day
detect
puuv
challeng
hamster
fig
htnv
im
infect
hamster
infecti
viru
first
detect
liver
begin
day
lung
liver
spleen
kidney
day
post
infect
fig
except
kidney
infecti
viru
recov
everi
hamster
day
post
infect
infecti
viru
recov
lung
liver
brain
spleen
portion
hamster
time
point
infecti
viru
detect
heart
time
point
fig
viru
recoveri
htnv
infect
hamster
markedli
lower
infecti
viru
detect
kidney
post
infect
fig
infecti
viru
recov
organ
puuv
infect
hamster
fig
confirm
lack
infecti
viru
spleen
due
presenc
inhibitor
select
sampl
spike
htnv
viru
prior
plaqu
assay
signific
inhibit
spike
rna
note
confirm
rtpcr
result
htnv
infect
result
viral
dissemin
spleen
fig
infecti
viru
detect
urin
hamster
test
even
rtpcr
posit
htnv
viral
genom
human
andv
infect
patient
andv
antigen
posit
urin
sampl
cultur
vero
cell
day
post
infect
infecti
viru
detect
three
htnv
rtpcr
posit
three
htnv
rtpcr
neg
urin
sampl
cultur
vero
cell
supernat
collect
variou
day
post
infect
evalu
rtpcr
fig
sampl
htnv
rtpcr
neg
viru
supernat
infect
cell
day
post
infect
first
time
point
examin
three
rtpcr
posit
urin
sampl
yield
infecti
viru
two
day
one
day
two
rtpcr
neg
urin
sampl
also
yield
infecti
viru
day
fig
measur
convers
cell
supernat
htnv
rtpcr
posit
sampl
evalu
plaqu
assay
day
post
infect
find
confirm
sampl
whose
cell
supernat
becam
rtpcr
posit
post
infect
posit
infecti
viru
plaqu
assay
one
sampl
whose
cell
supernat
convert
rtpcr
posit
remain
neg
infecti
viru
plaqu
assay
fig
patient
infect
hfr
hantavirus
exhibit
leukocytosi
thrombocytopenia
infect
everi
time
point
post
infect
edtatr
whole
blood
htnv
puuv
expos
hamster
evalu
determin
chang
white
blood
cell
count
platelet
occur
chang
observ
fig
character
diseas
tissu
section
htnv
im
infect
hamster
analyz
ihc
h
e
assess
viral
local
patholog
chang
fig
signific
histopatholog
find
note
kidney
brain
splenic
follicular
lymphoid
hyperplasia
hepat
extramedullari
hematopoiesi
liver
note
three
hamster
seen
anim
later
time
point
studi
day
like
repres
reaction
htnv
infect
though
unidentifi
antigen
stimuli
rule
five
hamster
day
post
infect
exhibit
minim
mild
inflamm
pericardium
character
mix
lymphoplasmacyt
histiocyt
neutrophil
infiltr
occasion
macrophag
inflammatori
infiltr
within
pericardium
immunoposit
suggest
possibl
associ
htnv
howev
evid
cardiac
tissu
injuri
associ
presenc
htnv
antigen
begin
day
post
infect
hamster
exhibit
minim
like
subclin
respiratori
lesion
consist
interstiti
neutrophil
histiocyt
infiltr
lung
also
exhibit
minim
amount
alveolar
edema
addit
hamster
minim
alveolar
edema
pulmonari
infiltr
find
suggest
respons
antigen
stimulu
presenc
immunoposit
endotheli
cell
pneumocyt
alveolar
macrophag
suggest
respons
htnv
infect
immunohistochemistri
stain
uniformli
neg
tissu
day
post
challeng
day
post
challeng
minim
antigen
sporad
detect
macrophag
pneumocyt
endotheli
cell
day
post
challeng
mild
moder
level
antigen
observ
endotheli
cell
choroid
ependym
cell
brain
endotheli
cell
macrophag
pneumocyt
lung
endotheli
cell
kidney
minim
mild
level
immunoposit
found
endotheli
cell
macrophag
heart
endotheli
cell
hepatocyt
kupffer
cell
liver
surprisingli
given
lack
viral
genom
infecti
viru
recov
mild
moder
amount
immunoposit
macrophag
lymphocyt
endotheli
cell
found
spleen
tabl
fig
publish
studi
detail
ferret
suscept
hantaviru
infect
examin
four
ferret
expos
either
pfu
htnv
puuv
seroconvers
occur
within
day
post
infect
anim
reexpos
either
pfu
htnv
pfu
puuv
beaumont
human
puuv
isol
pfu
puuv
seloign
vole
puuv
isol
im
prior
reexposur
one
seroneg
ferret
htnv
group
remov
health
concern
rapid
weight
loss
unrel
studi
cage
mate
subsequ
remov
behavior
health
reason
complet
studi
data
two
ferret
shown
soon
three
day
post
infect
ferret
began
lose
weight
htnv
infect
ferret
lose
peak
bodi
weight
puuv
infect
ferret
fig
day
post
infect
anim
develop
antibodi
strain
viru
measur
nelisa
assay
fig
neutral
antibodi
develop
began
earli
day
post
infect
ferret
develop
neutral
antibodi
day
post
infect
fig
edta
treat
blood
analyz
weekli
evid
leukocytosi
thrombocytopenia
none
observ
fig
serum
viremia
detect
rtpcr
fig
syrian
hamster
infect
snv
develop
lethal
diseas
unless
immunosuppress
day
post
infect
infect
ferret
administ
mgkg
cyp
within
two
day
post
administr
total
white
blood
cell
lymphocyt
neutrophil
count
decreas
significantli
fig
almost
zero
seven
day
post
administr
immunosuppress
ferret
rapidli
lost
weight
becam
letharg
occasion
vomit
diarrhea
anim
euthan
day
post
administr
cyp
met
human
endpoint
criteria
organ
infect
ferret
analyz
viral
load
rtpcr
presenc
infecti
viru
plaqu
assay
lung
liver
spleen
intestin
urin
htnv
infect
ferret
neg
viral
genom
small
amount
detect
heart
spleen
singl
anim
fig
heart
lung
kidney
intestin
urin
puuv
infect
ferret
neg
viral
genom
though
small
amount
detect
liver
spleen
puuv
infect
ferret
fig
viral
genom
spike
assay
confirm
lack
signal
due
presenc
inhibitor
organ
except
intestin
inhibit
rtpcr
product
similarli
infecti
viru
found
organ
ferret
plaqu
assay
despit
spikedin
viru
exhibit
signific
inhibit
fig
confirm
immunosuppress
uninfect
ferret
result
rapid
weight
loss
four
healthi
ferret
immunosuppress
load
dose
mgkg
cyp
follow
mgkg
cyp
mainten
dose
everi
day
fig
five
day
post
immunosuppress
ferret
exhibit
rapid
weight
loss
fever
lethargi
due
secondari
infect
fig
immunosupress
discontinu
mgkg
enrofloxicin
broad
spectrum
antibiot
given
twice
daili
week
time
ferret
began
gain
weight
fever
diminish
day
immunosupress
resum
two
dose
prophylact
enrofloxicin
given
daili
even
prophylact
antibiot
two
ferret
spike
fever
within
day
post
second
round
immunosuppress
treatment
though
lose
weight
fig
base
result
rapid
weight
loss
clinic
sign
observ
upon
immunosuppress
htnv
puuv
infect
ferret
like
due
secondari
infect
due
inabl
complet
manag
secondari
infect
prophylact
antibiot
treatment
immunosuppress
studi
carri
ferret
refin
hfrscaus
hantaviru
ferret
infect
model
four
ferret
challeng
pfu
puuv
beaumont
im
day
weight
temperatur
record
daili
twice
weekli
blood
draw
urin
collect
use
monitor
kidney
function
pilot
experi
ferret
slowli
lost
peak
bodi
weight
recapitul
previou
find
fig
elev
temperatur
observ
fig
ferret
develop
robust
antibodi
respons
begin
day
post
infect
fig
neutral
antibodi
develop
earli
day
post
infect
present
ferret
day
post
infect
measur
psvna
prnt
fig
despit
slow
weight
loss
sign
renal
impair
observ
proteinuria
hematuria
hallmark
puuv
infect
occur
proteinuria
hematuria
human
clinic
case
prolong
proteinuria
hematuria
observ
fig
infect
ferret
similarli
blood
urea
nitrogen
creatinin
level
sera
elev
due
kidney
failur
puuv
patient
remain
unchang
puuv
infect
ferret
fig
infecti
viru
viral
genom
detect
brain
heart
lung
liver
spleen
kidney
intestin
eye
fig
chang
serolog
urolog
paramet
note
fig
gross
patholog
chang
signific
lesion
associ
puuv
infect
note
ferret
fig
lung
one
ferret
mild
neutrophil
histiocyt
inflamm
center
bronchiol
expand
alveolar
septa
given
inflamm
center
around
bronchiol
vasculatur
unlik
respons
puuv
infect
number
common
ageassoci
lesion
observ
ferret
two
four
ferret
prolif
cortic
cell
either
adren
capsul
adren
cortex
like
clinic
silent
lack
clinic
sign
consist
endocrinopathi
addit
alveolar
miner
note
four
ferret
eosinophil
lymphoplasmacyt
enter
hepat
two
ferret
fibromyxomat
degener
atrioventricular
valv
spleen
brain
kidney
pituitari
gland
normal
ferret
examin
ferret
literatur
suscept
marmoset
hantaviru
infect
test
three
male
marmoset
expos
pfu
htnv
im
blood
collect
weekli
measur
seroconvers
serum
viremia
well
serum
paramet
relat
renal
function
three
anim
seroconvert
day
post
infect
fig
despit
display
clinic
sign
ill
neutral
antibodi
product
began
around
time
robust
day
post
infect
fig
due
low
volum
blood
drawn
time
point
serum
viremia
could
examin
individu
anim
howev
pool
sera
three
anim
evalu
time
point
post
infect
low
level
serum
viremia
detect
day
post
infect
rtpcr
fig
ferret
infect
model
hfrscaus
hantaviru
renal
injuri
measur
chang
note
blood
urea
nitrogen
serum
creatinin
observ
cours
infect
chang
serum
paramet
monitor
fig
anim
euthan
day
post
infect
examin
organ
viral
dissemin
infecti
viru
viral
genom
detect
heart
lung
liver
spleen
kidney
intestin
brain
fig
lymphoid
hyperplasia
note
three
anim
histolog
though
locat
intens
vari
spleen
variou
lymph
node
gut
associ
lymphoid
tissu
hyperplasia
indic
respons
antigen
stimul
like
caus
viral
challeng
mild
moder
congest
also
seen
lung
marmoset
howev
acut
chang
like
associ
termin
anesthesia
euthanasia
signific
histolog
lesion
note
three
anim
fig
due
neg
virolog
result
lack
signific
histolog
chang
ihc
detect
presenc
htnv
antigen
tissu
perform
htnv
puuv
determin
report
similar
lethal
dose
calcul
snv
andv
pfu
via
im
rout
also
similar
challeng
dose
andv
requir
infectkil
hamster
intragastr
rout
fold
higher
previou
report
also
demonstr
puuv
capabl
infect
hamster
intragastr
rout
make
much
less
effect
rout
infect
despit
similar
htnv
puuv
greatli
diverg
time
less
htnv
requir
infect
hamster
via
im
rout
fold
less
requir
infect
via
rout
tabl
lower
dose
coupl
viral
persist
htnv
infect
anim
oppos
viral
clearanc
fig
suggest
htnv
infecti
puuv
hamster
mechan
differ
close
relat
hantavirus
remain
unknown
lethal
infect
hamster
andv
lead
extens
organ
dissemin
infecti
viru
recov
lung
liver
kidney
spleen
heart
asymptomat
infect
hamster
snv
repeatedli
passag
hamster
similar
organ
distribut
organ
distribut
virus
similar
low
dose
htnv
hamster
model
two
notabl
except
first
htnv
model
low
transient
level
viru
liver
hardli
viru
spleen
fig
dissimilar
model
led
us
confirm
lack
viru
spleen
due
presenc
inhibitor
spike
either
infecti
viru
viral
rna
sampl
prior
evalu
fig
second
andv
model
presenc
viru
determin
plaqu
assay
indic
viru
infecti
replic
compet
htnv
low
dose
hamster
model
detect
high
level
viral
genom
case
htnv
im
model
patholog
rtpcr
recoveri
infecti
viru
sporad
typic
occur
low
level
hamster
per
time
point
fig
tabl
discrep
rtpcrpatholog
plaqu
assay
notabl
hamster
studi
perfus
given
appear
neutral
antibodi
earli
day
xx
post
infect
presenc
antibodi
could
impair
abil
recov
live
viru
via
plaqu
assay
also
possibl
viral
packag
somehow
impair
hamster
lead
larger
amount
nucleocapsid
protein
viral
genom
live
viru
studi
need
undertaken
elucid
low
dose
htnv
hamster
model
also
mimic
infect
pattern
viru
host
speci
stripe
field
mous
apodemu
agrariu
viral
genom
detect
lung
liver
kidney
spleen
heart
brain
examin
contrast
htnv
low
dose
model
organ
distribut
viru
puuv
low
dose
model
transient
puuv
im
infect
hamster
viru
detect
rtpcr
around
day
post
infect
viru
clear
organ
except
lung
day
infecti
viru
recov
time
point
examin
even
less
viru
detect
puuv
model
small
amount
brain
one
hamster
day
post
infect
neither
case
serum
viremia
observ
fig
similar
snv
model
involv
low
passag
viru
immunocompet
hamster
viru
transient
detect
lung
pcr
sporad
found
organ
day
post
infect
use
immunohistochemistri
distribut
puuv
hamster
differ
somewhat
host
speci
bank
vole
found
persist
lung
spleen
kidney
detect
heart
brain
seroconvers
hamster
post
viral
exposur
remain
best
way
measur
infect
consid
primari
endpoint
efficaci
studi
though
prnt
assay
slightli
sensit
nelisa
assay
detect
neutral
antibodi
anim
nelisa
titer
two
puuv
anim
nelisa
titer
increas
time
sampl
biosafeti
requir
necessari
prnt
assay
make
nelisa
better
choic
fig
fig
pfu
htnv
im
challeng
given
lower
titer
specif
od
sum
valu
compar
higher
challeng
dose
fact
one
hamster
signific
viral
genom
organ
day
post
infect
brain
kidney
seroconvert
wait
day
post
infect
monitor
seroconvers
advis
fig
viral
load
brain
kidney
lung
measur
rtpcr
need
evalu
day
post
lowdos
challeng
determin
use
secondari
endpoint
recoveri
infecti
viru
organ
viremia
sporad
serv
proxi
marker
infect
ferret
use
experiment
model
numer
hemorrhag
fever
virus
respiratori
virus
though
publish
report
exist
examin
suscept
hantaviru
infect
comparison
hamster
ferret
far
resist
htnv
puuv
infect
exposur
ferret
pfu
greater
virus
hamster
fail
result
product
infect
seroconvers
instead
im
challeng
dose
pfu
need
fig
initi
ferret
expos
puuv
commonli
use
laboratori
isol
cell
cultur
year
repeat
passag
hantaviru
known
caus
mutat
contrast
puuv
beaumont
seloign
rel
recent
isol
passag
cell
cultur
post
isol
strain
use
subsequ
experi
maxim
likelihood
puuv
caus
diseas
elimin
possibl
attenu
laboratori
strain
viru
despit
high
challeng
dose
use
recent
isol
elev
white
blood
cell
observ
cours
experi
patholog
organ
burden
detect
conclus
experi
nelisa
specif
od
sum
titer
remain
low
fig
fig
outcom
almost
ident
marburg
ravn
viru
infect
ferret
develop
neutral
antibodi
titer
sign
product
infect
occur
previou
experi
hamster
demonstr
pfu
gammairradi
andv
snv
suffici
caus
seroconvers
neither
gammairradi
pfu
puuv
thu
seroconvers
observ
ferret
though
low
like
due
reaction
larg
quantiti
antigen
administ
product
infect
puuv
antigen
viral
genom
infecti
viru
found
brain
pituitari
gland
lung
heart
liver
kidney
spleen
cerebrospin
fluid
gastrointestin
tract
human
patient
clinic
symptom
ne
though
pattern
viral
dissemin
vari
individu
acut
kidney
injuri
vision
disturb
includ
blur
vision
myopic
shift
len
thicken
pulmonari
involv
includ
pleural
effus
vascular
congest
renal
failur
occur
less
frequent
given
lack
high
neutral
antibodi
titer
could
aid
viral
clearanc
lack
viral
genom
ferret
organ
examin
rather
surpris
fig
furthermor
lack
viral
antigen
patholog
organ
test
suggest
either
transient
infect
clear
prior
day
post
infect
level
viru
low
undetect
test
use
viral
reservoir
outsid
organ
test
lack
detect
viru
surpris
given
gradual
weight
loss
infect
anim
exhibit
fig
anim
gain
weight
day
post
challeng
point
gradual
weight
loss
occur
regardless
htnv
puuv
challeng
viru
weight
loss
featur
ferret
model
infecti
diseas
pattern
observ
uniqu
ferret
infect
morbilliviru
avian
influenza
filovirus
rapidli
lose
weight
first
week
two
week
post
infect
infect
sever
acut
respiratori
syndrom
viru
result
signific
weight
loss
hamster
infect
snv
asymptomat
unless
hamster
immunosuppress
ferret
immunosuppress
day
post
infect
rapid
weight
loss
lethargi
ensur
fig
given
clinic
sign
also
observ
unchalleng
control
anim
fig
could
like
result
secondari
infect
drug
toxic
use
cyp
well
document
ferret
primarili
given
high
dose
emet
dosag
long
term
immunosuppress
found
dosag
use
studi
mgkg
success
reduc
white
blood
cell
level
ferret
demonstr
cyp
use
induc
longterm
immunosuppress
antibiot
given
control
secondari
infect
fig
despit
abl
detect
infecti
viru
viral
genom
kidney
hypothes
weight
loss
observ
could
due
kidney
failur
individu
hfr
exhibit
proteinuria
hematuria
indic
kidney
damag
addit
serum
blood
urea
nitrogen
creatinin
level
elev
hfr
patient
provid
second
way
measur
kidney
function
decreas
platelet
level
also
character
clinic
hfr
human
impair
coagul
second
experi
design
monitor
kidney
paramet
puuv
infect
ferret
exhibit
gradual
weight
loss
character
first
experi
howev
prolong
sign
clinic
kidney
failur
observ
blood
urea
nitrogen
creatinin
level
dramat
increas
five
week
studi
period
one
anim
exhibit
proteinuria
day
two
exhibit
hematuria
one
day
one
day
fig
similarli
paramet
monitor
renal
failur
thrombocytopenia
occur
puuv
infect
ferret
fig
caus
weight
loss
remain
undetermin
though
suscept
htnv
puuv
ferret
limit
use
studi
involv
medic
countermeasur
efficaci
test
ferret
larg
mass
even
adolesc
make
amount
test
articl
need
also
prohibit
larg
larg
challeng
dose
requir
infect
could
potenti
obscur
protect
effect
drug
vaccin
due
overwhelm
amount
viru
administ
moreov
although
anim
infect
result
neutral
antibodi
titer
small
result
potenti
sensit
issu
model
husbandri
handl
anim
procedur
also
substanti
difficult
hamster
lack
genet
similar
human
marmoset
possess
studi
demonstr
suscept
marmoset
htnv
infect
marmoset
repres
attract
model
test
vaccin
therapeut
hfrscaus
hantavirus
due
genet
similar
human
small
size
also
model
simpl
readout
infect
ie
robust
antibodi
product
measur
nelisa
psvna
make
determin
protect
vaccin
passiv
transfer
materi
straightforward
optim
model
name
determin
could
prove
import
pfu
challeng
dose
could
excess
high
prohibit
therapeut
effect
candid
medic
countermeasur
overal
marmoset
model
similar
ferret
hfrscaus
hantaviru
infect
model
hamster
though
key
differ
like
ferret
signific
patholog
abnorm
note
sign
renal
failur
observ
fig
serum
chemistri
valu
differ
normal
rang
except
albumin
total
bilirubin
amylas
valu
fell
outsid
normal
rang
chang
cours
infect
indic
problem
may
lie
refer
valu
use
piccolo
gener
chemistri
panel
use
evalu
paramet
optim
human
test
therefor
may
less
optim
evalu
marmoset
especi
paramet
addit
infecti
viru
viral
genom
recov
organ
day
post
infect
surpris
given
high
level
neutral
antibodi
present
earli
day
post
infect
fig
unlik
ferret
howev
marmoset
develop
except
high
neutral
antibodi
titer
display
lowlevel
serum
viremia
two
four
week
post
infect
fig
serum
viremia
significantli
lower
hamster
infect
htnv
anim
display
rtpcr
titer
hamster
infect
andv
infecti
viru
titer
prior
death
despit
exhibit
clinic
sign
diseas
model
robust
antibodi
respons
measur
prnt
psvna
nelisa
make
use
tool
evalu
vaccin
preor
postexposur
therapeut
paper
explor
use
three
laboratori
anim
speci
possibl
infect
diseas
model
hfrscaus
hantavirus
hamster
ferret
marmoset
model
especi
hamster
model
marmoset
model
use
evalu
medic
countermeasur
potenti
induc
steril
immun
marmoset
particularli
use
evalu
passiv
transfer
protect
human
antibodi
rel
genet
similar
speci
order
primat
small
size
marmoset
allow
test
smaller
volum
materi
would
requir
larger
speci
macaqu
